Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03491
Species: Homo sapiens
Position : chr20:48900221-48901229
Year: 2019
Title: Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  30659195
MONDO:
Tissue: Liver
Tissue Ontology ID: UBERON:0002107
Cell Source: Human normal liver cell
CVCL ID:
Cell Type: hepatocyte
Cell Ontology ID: CL:0000182
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay
High Throughput Method: MBDCap-seq, WGBS, ChIP-seq, RNA-seq, Hi-C
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, ChIP-RT-qPCR, RT-RT-qPCR, Western blot, Bisulfite pyrosequencing
About Target Gene
Target gene : CEBPB
About TF
TF name :
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_00836 chr20:48400000-49200000 Breast breast carcinoma cell breast carcinoma
E_00837 chr20:48400000-49200000 Breast breast carcinoma cell breast carcinoma
E_00363 chr20:48900221-48901229 Liver hepatocellular carcinoma cell hepatocellular carcinoma
E_03512 chr20:48900221-48901229 Liver hepatocellular carcinoma cell hepatocellular carcinoma
E_03513 chr20:48900221-48901229 Liver hepatocellular carcinoma cell hepatocellular carcinoma
Expression of Target Genes for the Enhancer